Fibronectin: a Characterisation of Somatic Mutation in Sturge-Weber Syndrome

Q. Zhou,J.W. Zheng
DOI: https://doi.org/10.1016/j.ijom.2009.03.702
2009-01-01
Abstract:Sturge-Weber syndrome (SWS) is a rare, congenital neurocutaneous disorder with a leptomeningeal, facial trigeminal nerve dominative area and choroidal angioma.The cause of this disease remains unclear. During to the occurrence of localised abnormality of blood vessel formation, somatic mutation has been put forward. Studies have indicated that fibronectin increased gene expression in the SWS port wine-derived fibroblasts. Fibronectin is an important extracellular matrix molecule with key roles in regulating angiogenesis and vasculogenesis, in maintenance of the blood-brain barrier, blood vessel structure and function, as well as brain tissue responses to seizures. This is consistent with the presence of a hypothesised somatic mutation underlying SWS. In this study, we have proposed that fibronectin may be a reflection of somatic mutation. Further research should be done to study the role of fibronectin in the pathogenesis of SWS. Understanding the pathophysiology of SWS will help us to establish future neuroprotective strategies and novel treatment modalities.
What problem does this paper attempt to address?